Medison is Israel’s leading pharmaceutical partner, uniquely qualified to provide the entire spectrum of integrated services for international companies in Israel’s healthcare market. Employing a comprehensive approach to marketing and service, Medison supplies and maintains long-standing relations with HMOs (Health Maintenance Organizations), local medical centers and physicians.
Backed by three generations of experience in the healthcare industry since 1937, Medison is uniquely qualified to provide the complete spectrum of integrated services for international companies looking to enter or expand their presence in the Israeli and Romanian healthcare markets.
We work together with our partners to meet unmet medical
needs in a diverse range of therapeutic fields:
- Rare Diseases
- Palliative Care
Meir Jakobsohn founded Medison Ltd. in 1996 and spearheaded its growth as a leading international marketing group. He is the third generation of his family to help shape the local healthcare industry. Previously Meir served as the Chief Operating Officer of M. Jakobsohn Ltd., led by Arye Jakobsohn. M. Jakobsohn Ltd. was a pioneer in opening the local market to global pharmaceutical concerns like Ciba-Geigy (Novartis), which it represented between 1937 and 1995. Meir holds a BA in Economics from Bar-Ilan University and an Executive MBA from Bradford University in the UK.
Meir brings over twenty years of experience in management, marketing and sales in the medical and diagnostic markets. Prior to joining the Medison Group, he served as Manager of OTC products at Ciba-Geigy (Novartis) representative Jakobsohn Ltd. Meir also served as Marketing Manager at Promedico Ltd., and as Managing Director of Pharmatope Ltd. Meir holds a B.A. in Social Sciences and Economics from Bar Ilan University and an MBA from Manchester University.
An experienced financial executive, Ariel served as Chief Financial Officer for the NSI Group and Sarel Products and Solutions for Advanced Medicine prior to joining the Medison Group. He is a qualified accountant in Israel since 1996, and holds a BCompt degree from UNISA (University of South-Africa) and an MBA from Harriott-Watt University (Scotland).
Mira manages the Pharma Division, specializing in Oncology, Hematology, Endocrinology and Human Genetic Therapies. Prior to joining the Medison Group in 2006, Mira served as a Sales Manager, Product Manager and Business Unit Manager for C.T.S. Ltd., and was a registered dietician at the Sheba Medical Center. Mira holds a B.Sc. in Biochemistry and Food Science from the Hebrew University of Jerusalem and an MBA from the Ono Academic College.
Yael is responsible for establishing global policies, procedures, compensation structures, organizational development, recruitment and benefits. In her role as Vice President for Compliance, Yael oversees Medison’s compliance program to ensure correlation with partners in all related ethical business. Yael joined the Medison Group after serving as Vice President of Human Resources at IXI Mobile Inc. There she provided executive coaching and guidance, as well as support with management development, organizational development, change management, talent review, and succession planning. Prior to IXI Mobile, Yael served as a senior Human Resources Manager at Terayon Communication Systems Ltd. Yael holds a B.A. (Honors) in Economics and an MBA (Honors) from the Israel College of Management.
Prof. Pines is a Clinical Associate Professor at Tel Aviv University’s Sackler School of Medicine. He brings extensive experience in conducting clinical trials for multinational companies, and has published over 100 studies in prestigious medical journals. Prof. Pines holds a B.Sc. in Biology from the Hebrew University of Jerusalem, and an M.D. from Hadassah Medical School, Jerusalem.
Adv. Yoel Lipschitz served as a Senior Executive with 18 years’ experience in Governmental, legal and regulatory management. Prior to joining Medison , Yoel was Deputy Director General for Health Care Organizations & Supplementary Insurance in the Ministry of Health and a member of the National Health Services Committee .Yoel specializes in policy setting, pharmaceuticals and medical devices Regulations, pricing and technology assessment. Yoel holds a LLB in Law, BA in Economics and an Executive MBA from Bar-Ilan University. Yoel also serves as General Manager at Lavi Medtech Ltd.
Gil joined Medison in 2015 and is responsible for the strategic development of Medison Group. Gil brings vast experience in business strategy, management consulting, corporate finance, private equity and capital markets. Prior to joining Medison, Gil has been a Vice President at the private equity fund Shamrock Israel, where he led multiple investments and acted as a Chairman and board member of multiple Israeli and International companies. Gil holds a BSc (cum laude) from the Technion, the Israel Institute of Technology, and an MBA from the Recanati Business School at Tel Aviv University.
Vision & Values
Driven by a mission to be the leading single address for partners and customers in Israel and Romania and to nurturing long-term employee loyalty and development, Medison strives to deliver innovative high quality products to patients in order to save lives and improve the quality of life.
WE STRIVE TO DELIVER THE MOST INNOVATIVE AND UNIQUE HEALTHCARE SOLUTIONS TO PATIENTS.
Quality Policies and Certificates
Facts & Figures
- Founded in 1996
- Led by the third generation of the Jakobsohn family, pharmaceutical industry pioneers in Israel since 1937
- Track record of maintaining long-term franchising, exceeding two decades, of small- to medium-sized pharmaceutical companies
- Among top 3 pharmaceutical companies in Israel by sales
- Over $170M sales revenues in 2017
- Full spectrum of services including registration, reimbursement, nursing, distribution, marketing, NIH, and more
- Upholds international standards of corporate governance, ethics and stringent transparency
- Operates in full compliance with GDP, cGMP and ISO standards
10 Hashiloach St. P.O.B 7090
Petach Tikva, 4917002, Israel